ARCHIVES

Tafinlar Subgroup Data Shows Median OS of 20 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

Cancer Education: NCI Offers Training In Epidemiology And Genetics

April 17, 1998

DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year

July 10, 1981

Sister Study To Examine Risk Factors For Breast Cancer In 50,000 Women

October 29, 2004

In Brief: Gallo Lists Followup Projects For Human Cancer Virus; Zubrod Responds To Cancer Program Critics

April 11, 1975

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007